PATENT CLAIM ANALYSIS

Application Number: 16219735
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "080000"]

Abstract:
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA): wherein R A , R B , R C , R D , and R E  are defined herein.

Claim (Index 52):
The method according to  claim 46 , wherein\n R A  is selected from the group consisting of C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy, C 3 -C 14 -carbocycle, (C 3 -C 14 -carbocyclo)-C 1 -C 6 -alkyl-, 3- to 14-membered heterocycle or heterocyclo(C 1 -C 6 -alkyl)- (wherein 1 to 4 heterocycle ring members are heteroatoms selected from N, O, and S), C 6 -C 14 -aryl, (C 6 -C 14 -aryl)-C 1 -C 6 -alkyl-, C 6 -C 14 -aryloxy, \u2014(CH 2 ) 0-6 NR 1 (CH 2 ) 0-6 C(O)R 2 , NR 1 R 2 , NR 1 C(NR 2 )NR 1 R 2 , \u2014CN, and \u2014OH.

Metadata:
- Claim Count in Document: 110.0
- Percentile: 98.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15691408', '14305393', '11487884', '12669843', '14982127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8061001581319566
- 35 USC 102 Novelty (BERT): 0.601153163010341
- Combined Prediction Score: 0.785605458619795
- Mean Citation Score: 379.887276
- Max Citation Score: 539.0189
- Similarity Product: 454.2739597774148

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test